EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials
A US House committee has launched an investigation into drug trials conducted in China by major pharmaceutical companies, including Merck and AbbVie.
📍 The outcome
House committee opened an investigation into Merck and AbbVie regarding drug trials in China tied to the military. Lawmakers also questioned Pfizer, Bristol Myers, and Eli Lilly over trial sites linked to military hospitals.
The story quieted without a definitive conclusion in the coverage.
Epilogue added 45d ago, after coverage quieted.
Who reported it (10)
- U.S. Congress Investigates Chinese Clinical Trials Tied to Military Capabilities 조선일보 · 48d ago
- Lawmakers press Eli Lilly for China drug trials tied to military-linked hospitals AOL.com · 48d ago
- US lawmakers demand national security probes into pharma trials in China Межа. Новини України. · 48d ago
- Lawmakers press Eli Lilly for China drug trials tied to military-linked hospitals Fox News · 48d ago
- U.S. House Committee Investigating Drugmakers Involved in China Drug Trials: Report Pharmaceutical Executive · 48d ago
- Pharmalittle: We're reading about Chinese trial sites being probed, RFK Jr. and peptides, and more statnews.com · 48d ago
- Drugmakers asked to defend Chinese trials; reports pharmaphorum · 48d ago
- Congress is investigating Merck and AbbVie over drug trials in China tied to its military qz.com · 48d ago
- Exclusive: House China panel questions Bristol Myers, Pfizer on trial sites Endpoints News · 48d ago
- EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials Reuters · 48d ago broke it first
What happened
A US House committee has opened an investigation into pharmaceutical companies regarding drug trials conducted in China. According to coverage from Reuters and QZ, the probe specifically focuses on Merck and AbbVie, with QZ noting ties between these trials and the Chinese military.
Reporting from Endpoints News indicates that the House China panel is also questioning Bristol Myers and Pfizer concerning trial sites. Pharmaphorum adds that drugmakers are being asked to defend these operations.
Future developments will depend on the responses of the questioned companies and the findings of the House committee's investigation into the trial sites.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 48d ago.
Questions people are asking
Which companies are being investigated?
Coverage identifies Merck and AbbVie as targets of the House committee investigation, while Endpoints News reports that Bristol Myers and Pfizer are also being questioned.
What is the primary concern regarding the trials?
According to QZ, the investigation involves drug trials in China that are tied to the Chinese military.
Which government body is conducting the probe?
The investigation is being led by a US House committee, specifically the House China panel.
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
People, places & organizations
Topics
From around our network
Related trends
China's recovery sputters as consumption, output lose steam
China's economic recovery is losing momentum as retail sales, output, and investment slow down.
China’s Xi praises former president Jiang’s contribution in show of party unity
Chinese President Xi Jinping marked the birth centenary of his late predecessor Jiang Zemin by praising party unity and past contributions.
As China Pushes to Expand in Asia, Trump Focuses on Iran
China expands its regional footprint while attention centers on Iran, prompting strategic assessments.
Trump administration to impose tariffs on drone imports, White House says
The Trump administration just set 100% tariffs on imported drones and aircraft parts, a move aimed at China and U.S. supply‑chain security
Typhoon Dolphin: China evacuates more than 1 million people as massive storm arrives
Typhoon Dolphin forces China to evacuate over a million as record rains batter Shanghai
Taipei says China's traffic control order for Taiwan Strait during typhoon is 'ridiculous'
Taipei has dismissed Beijing's Taiwan Strait traffic control order during a typhoon as ridiculous amidst rising regional tensions.